Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LILRB3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
mRNA | MYEOV | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
mRNA | FERD3L | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | IQCE | CTRPv2 | pan-cancer | AAC | 0.086 | 0.05 |
mRNA | IQCC | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | CEP350 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
mRNA | LHX8 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
mRNA | CELF6 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
mRNA | TNRC18 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | DYNLL2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |